HLS Therapeutics Inc. (TSE:HLS - Get Free Report) shares were down 0.2% during trading on Wednesday . The company traded as low as C$4.85 and last traded at C$4.87. Approximately 6,901 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 13,448 shares. The stock had previously closed at C$4.88.
Analyst Upgrades and Downgrades
Separately, Stifel Nicolaus raised their price target on HLS Therapeutics from C$3.50 to C$4.00 and gave the stock a "hold" rating in a research note on Wednesday, March 26th.
Read Our Latest Stock Analysis on HLS Therapeutics
HLS Therapeutics Stock Down 0.8%
The business has a 50-day simple moving average of C$4.81 and a two-hundred day simple moving average of C$4.37. The company has a debt-to-equity ratio of 86.50, a quick ratio of 1.01 and a current ratio of 1.56. The company has a market capitalization of C$107.46 million, a price-to-earnings ratio of -4.84 and a beta of 1.07.
About HLS Therapeutics
(
Get Free Report)
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris.
Featured Articles
Before you consider HLS Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HLS Therapeutics wasn't on the list.
While HLS Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.